Work

Effect of Zilucoplan on Myasthenia Gravis–Specific Outcome Subdomain Scores in RAISE: A Phase 3 Study (S34.004)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000208755

Authors: Michael D. Weiss, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, Yessar Hussain, M. Isabel Leite, Angelina Maniaol, Kimiaki Utsugisawa, Tuan Vu, Babak Boroojerdi, Fiona Grimson, Natasa Savic, James F. Howard

Institutions: University of Washington, University of Washington Medical Center, University of Kansas Medical Center, The Ohio State University Wexner Medical Center, The Ohio State University, Montreal Neurological Institute and Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, The University of Texas at Austin, University of Oxford, Oslo University Hospital, General Hanamaki Hospital, University of South Florida, UCB Pharma (Germany), UCB Pharma (United Kingdom), University of North Carolina at Chapel Hill

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409222440

FWCI:

Cites:

Cited by:

Related to: 10